Table 3. Comparison of outcome measurements.

	Stabilization exercise (n=30)	Conventional exercise (n=28)
Dependent variables	Mean±SD	Mean±SD	p full model* p within group p between group p time x group interaction	Post Hoc testε
VAS (0-10)
At baseline (Tb)	6.0±1.9	7.2±1.2	<0.001	Tb<Te
End of treatment (Te)	4.2±1.7	4.8±1.8	<0.001	Tb<T1
1 month (T1)	3.3±1.9	4.0±1.4	0.865 β	Tb<T3
3 months (T3)	3.4±1.8	4.4±1.9	0.601
BDI
At baseline (Tb)	11.1±10.6	12.6±8.9	<0.001	Tb<Te
End of treatment (Te)	6.5±7.5	10.5±8.0	<0.001	Tb<T1
1 month (T1)	6.1 ±7.1	7.7±6.0	0.137	Tb<T3
3 months (T3)	4.6±4.2	7.7±5.5	0.345	Te<T3
NDI
At baseline (Tb)	24.5±12	31.4±13.2	<0.001	Tb<Te
End of treatment (Te)	14.7±7.8	20.4±9.4	<0.001	Tb<T1
1 month (T1)	13.1±12.7	18.6±11.8	0.342 β	Tb<T3
3 months (T3)	13.6±10.4	17.3±8.6	0.740
Paracetamol intake (tablet/week)
At baseline (Tb)	1.4±4.0	1.5±3.5	0.102
End of treatment (Te)	1.7±4.3	0.9±2.1	0.100
1 month (T1)	0.9±2.9	0.6±1.9	0.570
3 months (T3)	0.7±2.8	0.3±0.9	0.718
SD: Standard deviation; VAS: Visual Analog Scale; BDI: Beck depression inventory; NDI: Neck disability index; β Comparison of the measurements of three differences between the four measuring points; ε Bonferroni post hoc test comparisons.